Subject: RE: 3-step approach in testing solutions in Georgia
From: Tamar Gabunia </O=EXCHORGANIZATION/OU=EXCHANGE ADMINISTRATIVE GROUP (FYDIBOHF23SPDLT)/CN=RECIPIENTS/CN=E6CA04F38EC94D0CADAB9CBDF90FCDDE-TAMAR G>
To: Mahsan Tajik <[email-masked]>, "Demirci, Hasan" <[email-masked]>
Cc: Burcak Celik <[email-masked]>
Date: Wed, 22 Apr 2020 05:31:15 +0000

Dear Mahsan

Many thanks for this introduction.

Dear Mr. Demirci and Dear Ms. Celik

I am delighted with this opportunity to work with you both on this very important initiative.

With kind regards and look forward

Tamar

პატივისცემით,

თამარ გაბუნია

მინისტრის პირველი მოადგილე

Sincerely,

Tamar Gabunia, MD, MPH

First Deputy Minister

From: Mahsan Tajik [mailto:[email-masked]]
Sent: 21 April, 2020 20:23
To: Demirci, Hasan <[email-masked]>
Cc: Burcak Celik <[email-masked]>; Tamar Gabunia <[email-masked]>
Subject: Re: 3-step approach in testing solutions in Georgia

Dear Mr. Demirci, dear Ms. Celik,

Thank you very much for your email. May I kindly inform you that I have already shared your email with Ms. Gabunia.

It is my pleasure to introduce to you Deputy Minister of IDP, Labour, Health and Social Affairs of Georgia, Ms. Gabunia. She is the person in charge and will take over the acquisition negotiations from here on in order to establish a direct and faster process.

I wish you a successful and fruitful cooperation and I thank you for your fast response.

Respectfully,

Mahsan Tajik

Mahsan Tajik

Director

Member of Board

INFINITART FOUNDATION

Tuchlauben 7a

1010 Vienna

Austria

Office      +43 1 25 300 25 261

Fax                          +43 1 25 300 25 25

Mobile     +43  664 547 0 355

------------------------------------------------------------------------------------------------------------------------------------------------------------------------

This e-mail contains confidential and legally privileged information. If you are not the intended recipient, you must not read, use, copy or disseminate this information. In this case please notify the Infinitart([email-masked]) of the fact that you have received this e-mail in error and immediately delete this e-mail.

Am 21.04.2020 schrieb Demirci, Hasan <[email-masked]>:

Dear Ms. Tajik,

Based on your discussion with Bernard Colombo today we would like to emphasize once again that we are ready to work together with you and support your efforts in fighting with the COVID-19 pandemic. We would like to share with you our three-step approach in supporting COVID-19 and Blood Safety testing needs in Georgia with a long term perspective.

1. Step - High Quality qPCR Solution for COVID-19

We have already been providing high quality qPCR testing solutions through our distributor Mirco to NCDC. We will keep providing and make sure the testing is available in Georgia before and after we deliver cobas 6800.

2. Step - cobas 6800 instrument and tests for COVID-19

We will order 1 cobas 6800 instrument and hopefully deliver it in the upcoming few months, probably towards Q3 2020. We will make sure that both high quality qPCR tests and cobas 6800 tests are available in Georgia. This way we will be prioritizing and contributing in COVID-19 pandemic management.

3. Step - cobas 6800 instrument and tests for Blood Safety Solution

We would like to plan together the optimal Blood Safety Solution with the relevant stakeholders in the longer run. This might be feasible Q4-2020 or Q1-2021.

Please note that cobas 6800 instrument can also be utilized for other virology and microbiology testing (HCV, HBV, HIV, HPV, CT/NG, MTB) which we see as an opportunity to further contribute to public health in Georgia.

We kindly ask your comments and look forward to discussing these matters through a web meeting.

Kind regards,

Hasan Demirci

Head of

Central Asia and Caucasian Countries

Roche Diagnostics

Roche Kazakhstan LLP

137, Luganskiy Street, Medeuskiy District

Almaty, 050051

Kazakhstan

Tel

: +

7 (727) 321 24 24

Mobile

: +7 (701) 351 91 69

________________________________________________________
Confidentiality Note:  This message is intended only for the use of the named recipients and may contain confidential and/or privileged information.  If you are not the intended recipient, please contact the sender and delete this message. Any unauthorized use of the information contained in this message is prohibited.